This book examines the financing of China’s health system, argues that present arrangements are not adequate and proposes an increased role for commercial health insurance as a way of overcoming the difficulties.
This book provides a systematic study of the challenges of aging in China and of the measures being taken, planned and still needed to cope with the challenges.
This book explores how medicines in China’s health care system are selected, procured and priced, together with reimbursement systems, the prescribing and usage of drugs, and the role that commercial insurance can play in paying for drugs.
This book provides a systematic study of the challenges of aging in China and of the measures being taken, planned and still needed to cope with the challenges.